All News

The Cuprimine brand and generic market had US sales of approximately $80 million for the most recent 12 months ending in June 2020.

First-of-its-kind consortium made up of health care industry leaders aims to establish standards for RFID use.

The keynote presentation will be broadcast virtually on 4 dates this fall and highlight cancer-specific guidance for pharmacists during the COVID-19 pandemic.

The 2019 survey results from the Monitoring the Future (MTF) study showed that vaping marijuana and nicotine rose sharply in the past 3 years among college age students, or students between 19 and 22 years of age.

Discontinuation of antidepressants should take place gradually, as abrupt stoppage or marked reduction in the dosage of an antidepressant is frequently associated with adverse effects (AEs), such as withdrawal symptoms.

A study of Chinese women found COVID-19 heightened stress, fear, and depression during pregnancy.

Researchers found that although the number of Medicare beneficiaries increased between 2014 and 2018, total costs decreased.

Magrolimab is a first-in-class, investigational anti-CD47 monoclonal antibody used in combination with azacitidine in treatment-naïve patients with high and very high-risk myelodysplastic syndrome,

Dr. Reddy’s Ciprofloxacin 0.3% and Dexamethasone 0.1% Otic Suspension, USP, is available as 7.5 mL fill in a 10 mL bottle.

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

Annual campaign encourages patients, colleagues, friends and family to recognize dedicated pharmacy professionals through social media.

Most notably, COVID-19 has transformed the landscape for medical science liaisons (MSLs) by forcing them to rapidly adapt to the present circumstances.

The types of SUDs investigated were tobacco, alcohol, opioid, cannabis, and cocaine.

It may take cells in different stages of development to cause breast cancer to progress and spread, according to recent research published in eLife.

The Mediterranean diet has shown efficacy in preventing several noncommunicable diseases.

Although the presence of rhinovirus limited the ability of influenza to infect cells, researchers do not know whether the same effect will be seen with COVID-19.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

The FDA grants fast track designation to the highly-selective N-terminal domain inhibitor EPI-7386 for the treatment of adult patients with metastatic castration-resistant prostate cancer.

Bristol Myers Squibb announced it will present data from research spanning 15 different cancers with high unmet need at the ESMO Virtual Congress 2020.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Levodopa may reduce the need for painful injections in patients with age-related macular degeneration.

Two phase 3 studies showed an investigational 15-valent pneumococcal conjugate vaccine (V114, Merck) was well-tolerated among patients and met the primary immunogenicity objectives.

Figuring out how to target vulnerable cells in breast cancer tumors can help treat the disease more effectively.

Study results provide an opportunity for pharmacists to ensure their patients are on an appropriate dosage or to council on alternatives for older adults at risk of cognitive decline.

The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.

Researchers believe the progression of allergies begins with eczema in infancy before progressing to food allergies, asthma, and hay fever later in childhood.

Successfully implementing HIV and hepatitis C testing at drug detoxification centers could help identify and link patients to care, but would require that the test results are available to nearby health care facilities.

Although the use of preexposure prophylaxis against HIV has increased across the United States in recent years, the rise in costs across the health care system has yet to be fully catalogued.

Pharmacy Times® interviewed Steven Lucio, vice president of Pharmacy Solutions at Vizient, on the ways that the COVID-19 pandemic has affected hospital spending this year, which is projected to result in increased drug spending for 2021.

The emergency use of drugs to shorten hospitalization and prolong time for COVID-19 vaccine research and development will serve as a critical temporary buffer for an efficient vaccine to combat SARS-CoV-2.